Sandbox Reserved 1703: Difference between revisions

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

@@ Line 22: / Line 22: @@
 ===Intermediate Form===
-No Cryo-EM structures are currently available for the intermediate form, but it is an important state for the full activation of mGlu2. While in the intermediate form, Glutamate, the agonist of mGlu2, binds both agonist binding sites. The <scene name='90/904308/Agonist_binding_site/4'>Agonist Binding Site</scene> is formed by both lobes of the VFT. The structure of mGlu2 will still remain in the inactive form upon two glutamates binding. The binding of glutamate, however, promotes signaling down the receptor <ref name="Lin" />.
+No Cryo-EM structures are currently available for the intermediate form, but it is an important state for the full activation of mGlu2. While in the intermediate form, Glutamate, the agonist of mGlu2, binds the agonist binding site. The <scene name='90/904308/Agonist_binding_site/4'>Agonist Binding Site</scene> is formed by both lobes of the VFT. The structure of mGlu2 will still remain in the inactive form upon two glutamates binding. The binding of glutamate, however, promotes signaling down the receptor <ref name="Lin" />.
 ===PAM and NAM Bound Form===
@@ Line 45: / Line 45: @@
 </StructureSection>
+==3D Structures==
+[[7mtq]], mGlu2 inactive <br />
+[[7mtr]], mGlu2 PAM bound <br />
+[[7mts]], mGlu2 active <br />
 == References ==
 <references/>
 ==Student Contributors==
-Frannie Brewer and Ashley Wilkinson
+Frannie Brewer
+Ashley Wilkinson